Title : Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China.

Pub. Date : 2021

PMID : 34957030






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sofosbuvir/velpatasvir (SOF/VEL) and sofosbuvir/ledipasvir (SOF/LDV) regimens became reimbursable in China in 2020. Sofosbuvir small integral membrane protein 1 (Vel blood group) Homo sapiens